Physician profile
Michael Donald Danko
NPI 1861654048
$381,173.07
in general payments reported to CMS, 2019-2025
51 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82K · 2020: $51K · 2021: $63K · 2022: $60K · 2023: $55K · 2024: $58K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Food and Beverage: $22K · Consulting Fee: $11K · Travel and Lodging: $10K · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,537.50 |
| Food and Beverage | $22,499.69 |
| Consulting Fee | $10,970.00 |
| Travel and Lodging | $10,156.37 |
| Education | $157.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $191,432.80 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Medtronic USA, INC. | $130,030.42 | 2019-2020 | |
| Boston Scientific Corporation | $16,026.17 | 2019-2025 | Precision, Wavewriter Alpha Prime 16, Na |
| Aurora Spine, INC. | $14,657.92 | 2022-2025 | Zip |
| Abbott Laboratories | $13,454.94 | 2019-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $3,371.97 | 2023-2025 | Evoke Scs, Evoke |
| Mml US, INC. | $1,922.82 | 2021-2022 | |
| Vertos Medical, INC. | $1,601.01 | 2019-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $1,326.22 | 2025 | Prospera |
| Nevro Corp. | $1,215.63 | 2019-2024 | Senza |
| Surgentec | $646.27 | 2021 | |
| Vertiflex, INC. | $635.49 | 2019 | |
| Relievant Medsystems, INC. | $576.37 | 2020-2021 | |
| Abbvie INC. | $556.10 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Curonix LLC | $419.75 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Danko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.